CARDIOVASCULAR JOURNAL OF AFRICA • Vol 21, No 2, March/April 2010
112
AFRICA
cases.
Ann Thorac Surg
2008;
85
: 56–58.
Khan M, Kalahasti V, Rajagopal V, Khaykin Y, Wazni O, Almahameed
4.
S,
et al
. Incidence of atrial fibrillation in heart transplant patients: long-
term follow-up.
J Cardiovasc Electrophysiol
2006;
17
: 827–831.
Lazzara R
5.
. Antiarrhythmic drugs and torsade de pointes.
Eur Heart J
1993;
14
(Suppl H): 88–92.
McComb JM, LoganKR, KhanMM, Geddes JS,AdgeyAA.
6.
Amiodarone-
induced ventricular fibrillation.
Eur J Cardiol
1980;
11
: 381–385.
Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB
7.
.
Precordial QT interval dispersion as a marker of torsade de pointes.
Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Circulation
1992;
86
: 1376–1382.
Schrickel J, Bielik H, Yang A, Schwab JO, Shlevkov N, Schimpf R,
8.
et al
.
Amiodarone-associated ‘torsade de pointes’. Relevance of concomitant
cardiovascular medication in a patient with atrial fibrillation and struc-
tural heart disease.
Z Kardiol
2003;
92
: 889–892.
Zipes DP, Prystowsky EN, Heger JJ
9.
. Amiodarone: electrophysiologic
actions, pharmacokinetics and clinical effects.
J Am Coll Cardiol
1984;
3
: 1059–1071.
[No authors listed
10.
]. Adverse effects of amiodarone: even after the end of
treatment.
Prescrire Int
2006;
15
: 62.
Nalli N, Stewart-Teixeira L, Dipchand AI
11.
. Amiodarone-sirolimus/
tacrolimus interaction in a pediatric heart transplant patient.
Pediatr
Transplant
2006;
10
: 736–739.
Chitwood KK, Abdul-Haqq AJ, Heim-Duthoy KL
12.
. Cyclosporine-
amiodarone interaction.
Ann Pharmacother
1993;
27
: 569–571.
Macdonald P, Hackworthy R, Keogh A, Sivathasan C, Chang V, Spratt P
13.
.
The effect of chronic amiodarone therapy before transplantation on early
cardiac allograft function.
J Heart Lung Transplant
1991;
10
: 743–749.
Preuner JG, Lehle K, Keyser A, Merk J, Rupprecht L, Goebels R
14.
.
Development of severe adverse effects after discontinuing amiodarone
therapy in human heart transplant recipients.
Transplant Proc
1998;
30
:
3943–3944.
Verani MS, Nishimura S, Mahmarian JJ, Hays JT, Young JB
15.
. Cardiac
function after orthotopic heart transplantation: response to postural
changes, exercise, and beta-adrenergic blockade.
J Heart LungTransplant
1994;
13
: 181–193.
Weiss MJ, Madsen JC, Rosengard BR, Allan JS
16.
. Mechanisms of chronic
rejection in cardiothoracic transplantation.
Front Biosci
2008;
13
:
2980–2988.
Ptaszek LM, Wang PJ, Hunt SA, Valantine H, Perlroth M, Al-Ahmad A
17.
.
Use of the implantable cardioverter-defibrillator in long-term survivors
of orthotopic heart transplantation.
Heart Rhythm
2005;
2
: 931–933.
Lorga-Filho A, Geelen P, Vanderheyden M, Malacky T, Primo J,
18.
Goethals M,
et al
. Early benefit of implantable cardioverter defibrilla-
tor therapy in patients waiting for cardiac transplantation.
Pacing Clin
Electrophysiol
1998;
21
: 1747–1750.
Grimm M, Grimm G, Zuckermann A, Wieselthaler G, Feuerstein M,
19.
Daneschvar H,
et al
. ICD therapy in survivors of sudden cardiac death
awaiting heart transplantation.
Ann Thorac Surg
1995;
59
: 916–920.
Podczeck A, Hief C, Jakl G, Frohner K, Nürnberg M, Kaltenbrunner W,
20.
et al
. [Efficacy of the implantable cardioverter-defibrillator in patients
on the waiting list for heart transplantation.]
Wien Klin Wochenschr
1995;
107
: 485–488.
Innovative approaches offer more at 2010 South African
Heart Association congress, 8–11 August, Sun City
The organisers of the 2010 South African Heart Association
congress (SAHA) are offering an innovative programme with
sessions in cardio-oncology (a first for South Africa), women’s
cardiovascular health, ethics, and South African scientific contri-
butions within the plenary sessions. Parallel sessions, although
necessary to cope with special-interest groups, will be kept to a
minimum. Interventional cardiology will be well covered.
The August timing of the congress has not deterred inter-
national interest and 16 overseas experts in the clinical, inter-
ventional and community health fields will participate in the
convention. The popular Mayo Clinic echocardiography work-
shop will be held on 8 August and will focus on new topics not
dealt with in earlier workshops held in South Africa.
The congress organising committee, under the chairmanship
of Dr Eric Klug, has kept price increases to a minimum. ‘We
are also providing incentives to delegates to register early and
as members of SAHA, thereby obtaining cheaper access.’As the
congress also includes a long weekend, family packages will be
available. An across-the-board subsidy for registration is being
considered.
The theme Holistic Healthcare, inspired by Dr Braunwald’s
previous appeals for improved overall care in cardiovascular
medicine, will be patient focused. ‘Our vision for this meeting is
to use creative means to enhance the clinician’s day-to-day skills,
with the end result that the patient sees our combined efforts as
co-ordinated, evidence based, sympathetic and ethical. We aim
to share frankly our experiences of success and failure in special
sessions devoted to
how I do it
and
lessons I have learned
, Dr
Klug said. A thought-provoking soapbox session on the last day
will include seven succinct presentations on controversial topics
in cardiovascular medicine. A wonderful social programme is
also being arranged.
SO DO NOT MISS THIS RAND-BASED OPPORTUNITY TO
HAVE THE BEST OF INTERNATIONAL CONTRIBUTIONS,
THE BEST AFRICA HAS TO OFFER.
GO TO THE WEBSITE TO SEE THE FULL PROGRAMME
AND REGISTER NOW!!
